South Korea is one of the fastest-growing medical device markets in Asia, offering significant opportunities for Indian manufacturers to expand internationally. However, before a medical device can be imported, distributed, or sold in South Korea, it must comply with the regulatory requirements of the Ministry of Food and Drug Safety (MFDS).
MFDS regulates the safety, quality, and performance of medical devices marketed in South Korea. The approval pathway depends on the device’s classification, intended use, risk level, and technical characteristics. Indian manufacturers must submit comprehensive legal, technical, quality, and safety documentation to demonstrate that their device meets Korean regulatory standards.
This guide provides a practical checklist of the essential documents generally required for MFDS medical device approval for Indian manufacturers.
MFDS approval is generally required for all Indian manufacturers intending to export medical devices to South Korea. The approval process applies to:
Before commercial sale, the product must follow the applicable MFDS notification, certification, or approval pathway based on its risk classification and intended use.
MFDS classifies medical devices into four risk-based categories:
| Device Class | Risk Level | General Regulatory Pathway |
| Class I | Low Risk | Notification |
| Class II | Low to Moderate Risk | Certification / Approval |
| Class III | Moderate to High Risk | MFDS Approval |
| Class IV | High Risk | MFDS Approval |
The classification is determined based on factors such as:
Correct classification is the first and most critical step before preparing the technical dossier.
Indian manufacturers should prepare a complete documentation package that generally includes the following:
Preparing accurate and consistent documentation significantly reduces the chances of regulatory queries and approval delays.
The general approval process involves the following steps:
| Activity | Estimated Timeline |
| Product Classification | 1–2 Weeks |
| Documentation Preparation | 3–6 Weeks |
| Technical Review | 2–4 Months |
| Query Resolution | Depends on MFDS |
| Final Approval | Approximately 3–6 Months |
The actual timeline depends on the device class, completeness of documentation, and regulatory review.
MFDS fees are not fixed for every product. The total cost depends on:
Therefore, manufacturers should obtain a project-specific cost estimate before filing the application.
Post-Approval Compliance
Receiving MFDS approval is only the beginning of regulatory compliance. Manufacturers must continue to comply with Korean regulatory requirements throughout the product lifecycle.
Key post-approval obligations include:
Failure to comply with post-market obligations may result in regulatory action, suspension, or cancellation of product approval.
No. Indian manufacturers must obtain the applicable MFDS approval before marketing medical devices in South Korea.
Yes. A valid ISO 13485 Quality Management System certificate is generally expected for medical device manufacturers.
Yes. A local Korean importer or authorized representative is generally required for product registration and import.
No. Clinical evidence requirements depend on the device classification, intended use, and regulatory pathway.
Most applications are completed within 3–6 months, depending on documentation quality and regulatory queries.
Yes. ELT Corporate Private Limited provides end-to-end support for MFDS medical device approval, including product classification, documentation review, technical dossier preparation, Korean importer coordination, query handling, and post-approval regulatory compliance for Indian manufacturers.
